⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
KROS News
Keros Therapeutics, Inc. Common Stock
Form 8-K
sec.gov
KROS
Keros Therapeutics Appoints Anne Prener to its Board of Directors
globenewswire.com
KROS
Form 8-K
sec.gov
KROS
Form 8-K
sec.gov
KROS
Keros Therapeutics Announces Participation at Goldman Sachs 47th Annual Global Healthcare Conference
globenewswire.com
KROS
Form 8-K
sec.gov
KROS
Keros Therapeutics Reports Recent First Quarter 2026 Financial Results
globenewswire.com
KROS
Kuros Biosciences appoints I.V. Hall as Chief Operating Officer, deepening operational, R&D and extremities leadership for next phase of growth
globenewswire.com
KROS
Global Food Processing Market Poised for Strong Growth as Rising Demand for Processed Foods, Automation, and Supply Chain Modernization Accelerate Adoption: Verified Market Research®
globenewswire.com
KROS
Form 8-K
sec.gov
KROS